Scienture Holdings, Inc. announced entering into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at an offering price of $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting placement agent fees and other offering expenses.
The offering, a registered direct offering, is expected to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock to be purchased at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million before deductions.
Closing Date
Expected to be on August 15, 2025, subject to customary conditions.
- The offering is a significant move by Scienture Holdings, Inc. to raise capital through institutional investors.
- This agreement showcases investor confidence in Scienture's future and potential growth in the pharmaceutical industry.
Scienture Holdings, Inc.'s securities purchase agreement marks a strategic step towards enhancing value for patients, physicians, and caregivers through novel specialty products.